156 related articles for article (PubMed ID: 2459554)
1. The pharmacology of epanolol (ICI 141292)--a new beta 1-selective adrenoceptor partial agonist.
Bilski AJ; Hadfield SE; Wale JL
J Cardiovasc Pharmacol; 1988 Aug; 12(2):227-32. PubMed ID: 2459554
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
3. Beta 1- and beta 2-adrenoceptor antagonist activities of ICI-215001, a putative beta 3-adrenoceptor agonist.
Tesfamariam B; Allen GT
Br J Pharmacol; 1994 May; 112(1):55-8. PubMed ID: 7913381
[TBL] [Abstract][Full Text] [Related]
4. The pharmacology of a beta 2-selective adrenoceptor antagonist (ICI 118,551).
Bilski AJ; Halliday SE; Fitzgerald JD; Wale JL
J Cardiovasc Pharmacol; 1983; 5(3):430-7. PubMed ID: 6191142
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacology of epanolol. Pharmacodynamic aspects.
Harry JD
Drugs; 1989; 38 Suppl 2():18-27. PubMed ID: 2575976
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the beta-adrenoceptor affinity and selectivity of cetamolol, atenolol, betaxolol, and ICI-118,551.
Rimele TJ; Henry DE; Giesa FR; Buckley SK; Geiger G; Heaslip RJ; Lee DK; Grimes D
J Cardiovasc Pharmacol; 1988 Aug; 12(2):208-17. PubMed ID: 2459552
[TBL] [Abstract][Full Text] [Related]
7. Atypical responses of rat ileum to pindolol, cyanopindolol and iodocyanopindolol.
Hoey A; Jackson C; Pegg G; Sillence M
Br J Pharmacol; 1996 Feb; 117(4):712-6. PubMed ID: 8646418
[TBL] [Abstract][Full Text] [Related]
8. Mediation of the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat by atypical beta-adrenoceptors, different from beta 3-adrenoceptors.
Malinowska B; Schlicker E
Br J Pharmacol; 1996 Mar; 117(5):943-9. PubMed ID: 8851515
[TBL] [Abstract][Full Text] [Related]
9. Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat.
Kaumann AJ; Molenaar P
Br J Pharmacol; 1996 Aug; 118(8):2085-98. PubMed ID: 8864547
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the profiles of agonists as stimulants of the beta 3-adrenoceptor in vitro with their gastroprotective effects in the conscious rat.
Bahl AK; Clayton NM; Coates J; Martin DP; Oakley IG; Strong P; Trevethick MA
Br J Pharmacol; 1996 Feb; 117(3):580-586. PubMed ID: 8821552
[TBL] [Abstract][Full Text] [Related]
11. Effects of beta-adrenoceptor blockade on heart rate and physiological tremor in diabetics with autonomic neuropathy. A comparative study of epanolol, atenolol and pindolol.
Reid W; Ewing DJ; Harry JD; Smith HJ; Neilson JM; Clarke BF
Br J Clin Pharmacol; 1987 Apr; 23(4):383-9. PubMed ID: 2883987
[TBL] [Abstract][Full Text] [Related]
12. Further evidence for differences between cardiac atypical beta-adrenoceptors and brown adipose tissue beta3-adrenoceptors in the pithed rat.
Malinowska B; Schlicker E
Br J Pharmacol; 1997 Dec; 122(7):1307-14. PubMed ID: 9421276
[TBL] [Abstract][Full Text] [Related]
13. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
Yeh JL; Liou SF; Liang JC; Huang YC; Chiang LC; Wu JR; Lin YT; Chen IJ
J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
[TBL] [Abstract][Full Text] [Related]
14. Celiprolol: agonist and antagonist effects at cardiac beta 1- and vascular beta 2-adrenoceptors determined under in vivo conditions in the rat.
Alvarez-Guerra M; Alda O; Garay RP
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):689-98. PubMed ID: 9205952
[TBL] [Abstract][Full Text] [Related]
15. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
McCaffrey PM; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
[TBL] [Abstract][Full Text] [Related]
16. The in vitro pharmacology of xamoterol (ICI 118,587).
Malta E; Mian MA; Raper C
Br J Pharmacol; 1985 May; 85(1):179-87. PubMed ID: 2862938
[TBL] [Abstract][Full Text] [Related]
17. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
[TBL] [Abstract][Full Text] [Related]
18. Functional identification of rat atypical beta-adrenoceptors by the first beta 3-selective antagonists, aryloxypropanolaminotetralins.
Manara L; Badone D; Baroni M; Boccardi G; Cecchi R; Croci T; Giudice A; Guzzi U; Landi M; Le Fur G
Br J Pharmacol; 1996 Feb; 117(3):435-442. PubMed ID: 8821531
[TBL] [Abstract][Full Text] [Related]
19. Influence of adrenodemedullation on beta 2- and beta 3-adrenoceptors mediating relaxation of oesophageal smooth muscle of spontaneously hypertensive rats.
de Boer RE; Steegstra MR; Kroezen PA; Smit J; Zaagsma J
Br J Pharmacol; 1996 Dec; 119(7):1355-60. PubMed ID: 8968543
[TBL] [Abstract][Full Text] [Related]
20. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ
Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
